Overview

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

Status:
Completed

Trial end date:
2009-11-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to demonstrate safety and efficacy of Olopatadine 0.2% compared to its vehicle in Japanese subjects in the treatment of acute allergen-mediated conjunctivitis using the conjunctival allergen challenge (CAC) test.

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

Olopatadine Hydrochloride
Ophthalmic Solutions
Pharmaceutical Solutions